Detalhe da pesquisa
1.
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
PLoS Med
; 17(9): e1003222, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956407
2.
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.
Pharmacol Res
; 136: 140-150, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30219580
3.
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.
Neurology
; 102(5): e208112, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335499
4.
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
JAMA Netw Open
; 5(1): e2144178, 2022 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076703
5.
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
JAMA Neurol
; 79(10): 1005-1014, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036925
6.
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function.
Neurology
; 93(13): e1312-e1323, 2019 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31451516
7.
Cyclooxygenase-2 inhibitors: promise or peril?
Mediators Inflamm
; 11(5): 275-86, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12467519
8.
Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
Arthritis Rheum
; 48(10): 2763-8, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14558080
9.
Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial.
Arthritis Rheum
; 48(12): 3328-37, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14673984